- Home
- OPRT vs BDTX Comparison
OPRT vs BDTX Comparison
Compare OPRT & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OPRT
- BDTX
- Stock Information
- Founded
- OPRT 2005
- BDTX 2014
- Country
- OPRT United States
- BDTX United States
- Employees
- OPRT N/A
- BDTX N/A
- Industry
- OPRT Finance: Consumer Services
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OPRT Finance
- BDTX Health Care
- Exchange
- OPRT Nasdaq
- BDTX Nasdaq
- Market Cap
- OPRT 146.4M
- BDTX 144.9M
- IPO Year
- OPRT 2019
- BDTX 2020
- Fundamental
- Price
- OPRT $3.93
- BDTX $2.20
- Analyst Decision
- OPRT Buy
- BDTX Strong Buy
- Analyst Count
- OPRT 4
- BDTX 4
- Target Price
- OPRT $5.17
- BDTX $15.50
- AVG Volume (30 Days)
- OPRT 187.8K
- BDTX 1.2M
- Earning Date
- OPRT 03-11-2025
- BDTX 03-11-2025
- Dividend Yield
- OPRT N/A
- BDTX N/A
- EPS Growth
- OPRT N/A
- BDTX N/A
- EPS
- OPRT N/A
- BDTX N/A
- Revenue
- OPRT $796,991,000.00
- BDTX N/A
- Revenue This Year
- OPRT N/A
- BDTX N/A
- Revenue Next Year
- OPRT $2.36
- BDTX N/A
- P/E Ratio
- OPRT N/A
- BDTX N/A
- Revenue Growth
- OPRT N/A
- BDTX N/A
- 52 Week Low
- OPRT $2.05
- BDTX $1.91
- 52 Week High
- OPRT $4.60
- BDTX $7.66
- Technical
- Relative Strength Index (RSI)
- OPRT 55.34
- BDTX 46.41
- Support Level
- OPRT $3.45
- BDTX $2.02
- Resistance Level
- OPRT $3.95
- BDTX $2.33
- Average True Range (ATR)
- OPRT 0.17
- BDTX 0.18
- MACD
- OPRT -0.02
- BDTX 0.03
- Stochastic Oscillator
- OPRT 57.83
- BDTX 38.16
About OPRT Oportun Financial Corporation
Oportun Financial Corp is engaged in providing financial services to people who either do not have a credit score or who may have a limited credit history. The company offers Personal Loans, Auto Loans, unsecured personal loans, and secured personal loans, and provides deposit accounts, debit card services, and other transaction services to its customers. Its product offerings include small-dollar, unsecured installment loans and other products and services.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.